Heska (HSKA) Tops Q4 EPS by 38c
Tweet
Share
E-mailGet Alerts HSKA Hot Sheet
Price: $119.99 --0%
Financial Fact:
Other vaccines, pharmaceuticals and products: 7.04M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Financial Fact:
Other vaccines, pharmaceuticals and products: 7.04M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Heska (NASDAQ: HSKA) reported Q4 EPS of $0.35, $0.38 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $68.1 million versus the consensus estimate of $66.02 million.
GUIDANCE:
Heska sees FY2022 revenue of $287-297 million, versus the consensus of $284.5 million.
For earnings history and earnings-related data on Heska (HSKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
- World Acceptance (WRLD) Tops Q1 EPS by 168c
- ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
